Schonfeld Strategic Advisors’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $439K | Sell |
53,928
-82,560
| -60% | -$672K | ﹤0.01% | 1499 |
|
|
2025
Q1 | $1.07M | Buy |
136,488
+1,491
| +1% | +$11.7K | 0.01% | 1150 |
|
|
2024
Q4 | $2.01M | Sell |
134,997
-538,841
| -80% | -$8.02M | 0.01% | 774 |
|
|
2024
Q3 | $10.3M | Buy |
673,838
+441,044
| +189% | +$6.74M | 0.07% | 239 |
|
|
2024
Q2 | $3.55M | Buy |
232,794
+128,934
| +124% | +$1.96M | 0.02% | 577 |
|
|
2024
Q1 | $1.96M | Sell |
103,860
-126,960
| -55% | -$2.4M | 0.01% | 843 |
|
|
2023
Q4 | $4.41M | Buy |
230,820
+87,920
| +62% | +$1.68M | 0.03% | 500 |
|
|
2023
Q3 | $2.57M | Sell |
142,900
-40,124
| -22% | -$720K | 0.02% | 644 |
|
|
2023
Q2 | $3.72M | Sell |
183,024
-110,786
| -38% | -$2.25M | 0.03% | 570 |
|
|
2023
Q1 | $5.36M | Buy |
293,810
+139,471
| +90% | +$2.54M | 0.05% | 427 |
|
|
2022
Q4 | $3.19M | Buy |
154,339
+23,711
| +18% | +$490K | 0.03% | 640 |
|
|
2022
Q3 | $3.42M | Sell |
130,628
-34,960
| -21% | -$914K | 0.03% | 665 |
|
|
2022
Q2 | $4.2M | Buy |
+165,588
| New | +$4.2M | 0.04% | 483 |
|
|
2022
Q1 | – | Sell |
-24,900
| Closed | -$1.01M | – | 2656 |
|
|
2021
Q4 | $1.01M | Buy |
24,900
+500
| +2% | +$20.2K | 0.01% | 879 |
|
|
2021
Q3 | $851K | Buy |
+24,400
| New | +$851K | 0.01% | 952 |
|
|
2021
Q2 | – | Sell |
-50,701
| Closed | -$1.42M | – | 2185 |
|
|
2021
Q1 | $1.42M | Buy |
50,701
+35,076
| +224% | +$985K | 0.02% | 739 |
|
|
2020
Q4 | $406K | Buy |
+15,625
| New | +$406K | 0.01% | 1071 |
|